ArticleFrontiers in neurology2013
Application of blood-based biomarkers in human mild traumatic brain injury.
Article in Frontiers in neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Integrated Blood Biomarker and Neurobehavioural Signatures of Latent Neuroinjury in Experienced Military Breachers Exposed to Repetitive Low-Intensity Blast.International journal of molecular sciences · 2026Article
- mTBI Biological Biomarkers as Predictors of Postconcussion Syndrome-Review.Brain sciences · 2024Review
- Levels of biomarkers associated with subconcussive head hits in mixed martial arts fighters.PeerJ · 2024Article
- Methodology Matters: Comparing Approaches for Defining Persistent Symptoms after Mild Traumatic Brain Injury.Neurotrauma reports · 2021Article
- Extracellular matrix proteins are time-dependent and regional-specific markers in experimental diffuse brain injury.Brain and behavior · 2020Article
- Neuron-Derived Plasma Exosome Proteins after Remote Traumatic Brain Injury.Journal of neurotrauma · 2020Article
- Towards the Development of an Integrative, Evidence-Based Suite of Indicators for the Prediction of Outcome Following Mild Traumatic Brain Injury: Results from a Pilot Study.Brain sciences · 2020Article
- Neuron-Derived Exosome Proteins May Contribute to Progression From Repetitive Mild Traumatic Brain Injuries to Chronic Traumatic Encephalopathy.Frontiers in neuroscience · 2019Article
- Diagnostic Potential of Neural Exosome Cargo as Biomarkers for Acute Brain Injury.Annals of clinical and translational neurology · 2018Article
- Unbiased Proteomic Approach Identifies Unique and Coincidental Plasma Biomarkers in Repetitive mTBI and AD Pathogenesis.Frontiers in aging neuroscience · 2018Article
- Review of the potential use of blood neuro-biomarkers in the diagnosis of mild traumatic brain injury.Clinical and experimental emergency medicine · 2017Review
- Is temperature an important variable in recovery after mild traumatic brain injury?F1000Research · 2017Review
- Blood biomarkers for brain injury: What are we measuring?Neuroscience and biobehavioral reviews · 2016Review
- Altered Blood Biomarker Profiles in Athletes with a History of Repetitive Head Impacts.PloS one · 2016Article
- The Pathophysiology of Sports Concussion.Current pain and headache reports · 2015Review
- S100B and Glial Fibrillary Acidic Protein as Indexes to Monitor Damage Severity in an In Vitro Model of Traumatic Brain Injury.Neurochemical research · 2015Article
- Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome.Frontiers in neurology · 2015Article
- Filling in the gaps: Anticipatory control of eye movements in chronic mild traumatic brain injury.NeuroImage. Clinical · 2015Article
- Multivariate analysis of traumatic brain injury: development of an assessment score.Frontiers in neurology · 2015Article
- Networks of neuroinjury semantic predications to identify biomarkers for mild traumatic brain injury.Journal of biomedical semantics · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic Brain Injury (TBI) is a global health concern. The majority of TBI's are mild, yet our ability to diagnose and treat mild traumatic brain injury (mTBI) is lacking. This deficiency results from a variety of issues including the difficulty in interpreting ambiguous clinically presented symptoms, and ineffective imaging techniques. Thus, researchers have begun to explore cellular and molecular based approaches to improve both diagnosis and prognosis. This has been met with a variety of challenges, including difficulty in relating biological markers to current clinical symptoms, and overcoming our lack of fundamental understanding of the pathophysiology of mTBI. However, recent adoption of high throughput technologies and a change in focus from the identification of single to multiple markers has given just optimism to mTBI research. The purpose of this review is to highlight a number of current experimental peripheral blood biomarkers of mTBI, as well as comment on the issues surrounding their clinical application and utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.